<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>7</number>
    <updateDate>2023-01-15T21:34:05Z</updateDate>
    <updateDateIncludingText>2023-01-15T21:34:05Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2003-01-07</introducedDate>
    <congress>108</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2003-01-07T22:47:33Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2003-01-07</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2003-01-07</actionDate>
        <text>Sponsor introductory remarks on measure. (CR 1/9/2003 S134)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-01-07</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>D000064</bioguideId>
        <fullName>Sen. Daschle, Thomas A. [D-SD]</fullName>
        <firstName>THOMAS</firstName>
        <lastName>DASCHLE</lastName>
        <party>D</party>
        <state>SD</state>
        <middleName>ANDREW</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>R000361</bioguideId>
        <fullName>Sen. Rockefeller, John D., IV [D-WV]</fullName>
        <firstName>JAY</firstName>
        <lastName>ROCKEFELLER</lastName>
        <party>D</party>
        <state>WV</state>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000770</bioguideId>
        <fullName>Sen. Stabenow, Debbie [D-MI]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Stabenow</lastName>
        <party>D</party>
        <state>MI</state>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000148</bioguideId>
        <fullName>Sen. Schumer, Charles E. [D-NY]</fullName>
        <firstName>Charles</firstName>
        <lastName>Schumer</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>E.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000105</bioguideId>
        <fullName>Sen. Kennedy, Edward M. [D-MA]</fullName>
        <firstName>EDWARD</firstName>
        <lastName>KENNEDY</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>MOORE</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001041</bioguideId>
        <fullName>Sen. Clinton, Hillary Rodham [D-NY]</fullName>
        <firstName>HILLARY</firstName>
        <lastName>CLINTON</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>R</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>A000069</bioguideId>
        <fullName>Sen. Akaka, Daniel K. [D-HI]</fullName>
        <firstName>DANIEL</firstName>
        <lastName>AKAKA</lastName>
        <party>D</party>
        <state>HI</state>
        <middleName>KOHIKINA</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001042</bioguideId>
        <fullName>Sen. Corzine, Jon S. [D-NJ]</fullName>
        <firstName>JON</firstName>
        <lastName>CORZINE</lastName>
        <party>D</party>
        <state>NJ</state>
        <middleName>S.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M000702</bioguideId>
        <fullName>Sen. Mikulski, Barbara A. [D-MD]</fullName>
        <firstName>BARBARA</firstName>
        <lastName>MIKULSKI</lastName>
        <party>D</party>
        <state>MD</state>
        <middleName>ANN</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000174</bioguideId>
        <fullName>Sen. Leahy, Patrick J. [D-VT]</fullName>
        <firstName>Patrick</firstName>
        <lastName>Leahy</lastName>
        <party>D</party>
        <state>VT</state>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000261</bioguideId>
        <fullName>Sen. Levin, Carl [D-MI]</fullName>
        <firstName>CARL</firstName>
        <lastName>LEVIN</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>MILTON</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000177</bioguideId>
        <fullName>Sen. Johnson, Tim [D-SD]</fullName>
        <firstName>TIM</firstName>
        <lastName>JOHNSON</lastName>
        <party>D</party>
        <state>SD</state>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000122</bioguideId>
        <fullName>Sen. Reed, Jack [D-RI]</fullName>
        <firstName>John</firstName>
        <lastName>Reed</lastName>
        <party>D</party>
        <state>RI</state>
        <middleName>F.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000064</bioguideId>
        <fullName>Sen. Sarbanes, Paul S. [D-MD]</fullName>
        <firstName>PAUL</firstName>
        <lastName>SARBANES</lastName>
        <party>D</party>
        <state>MD</state>
        <middleName>SPYROS</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000596</bioguideId>
        <fullName>Sen. Dayton, Mark [D-MN]</fullName>
        <firstName>MARK</firstName>
        <lastName>DAYTON</lastName>
        <party>D</party>
        <state>MN</state>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000123</bioguideId>
        <fullName>Sen. Lautenberg, Frank R. [D-NJ]</fullName>
        <firstName>FRANK</firstName>
        <lastName>LAUTENBERG</lastName>
        <party>D</party>
        <state>NJ</state>
        <middleName>R.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000146</bioguideId>
        <fullName>Sen. Reid, Harry [D-NV]</fullName>
        <firstName>HARRY</firstName>
        <lastName>REID</lastName>
        <party>D</party>
        <state>NV</state>
        <middleName>M.</middleName>
        <sponsorshipDate>2003-01-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000388</bioguideId>
        <fullName>Sen. Dodd, Christopher J. [D-CT]</fullName>
        <firstName>CHRISTOPHER</firstName>
        <lastName>DODD</lastName>
        <party>D</party>
        <state>CT</state>
        <middleName>JOHN</middleName>
        <sponsorshipDate>2003-01-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000711</bioguideId>
        <fullName>Sen. Boxer, Barbara [D-CA]</fullName>
        <firstName>BARBARA</firstName>
        <lastName>BOXER</lastName>
        <party>D</party>
        <state>CA</state>
        <sponsorshipDate>2003-01-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001210</bioguideId>
        <fullName>Sen. Byrd, Robert C. [D-WV]</fullName>
        <firstName>ROBERT</firstName>
        <lastName>BYRD</lastName>
        <party>D</party>
        <state>WV</state>
        <middleName>CARLYLE</middleName>
        <sponsorshipDate>2003-02-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>N000032</bioguideId>
        <fullName>Sen. Nelson, Bill [D-FL]</fullName>
        <firstName>CLARENCE</firstName>
        <lastName>NELSON</lastName>
        <party>D</party>
        <state>FL</state>
        <middleName>WILLIAM</middleName>
        <sponsorshipDate>2003-04-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative procedure</name>
        </item>
        <item>
          <name>Ambulatory care</name>
        </item>
        <item>
          <name>Armed Forces and National Security</name>
        </item>
        <item>
          <name>Auditing</name>
        </item>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Canada</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Civil Rights and Liberties, Minority Issues</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Communication in medicine</name>
        </item>
        <item>
          <name>Conflict of interests</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Consent decrees</name>
        </item>
        <item>
          <name>Consumer education</name>
        </item>
        <item>
          <name>Consumer organizations</name>
        </item>
        <item>
          <name>Continuum of care</name>
        </item>
        <item>
          <name>Crime and Law Enforcement</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>District of Columbia</name>
        </item>
        <item>
          <name>Drug advertising</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drug interactions</name>
        </item>
        <item>
          <name>Drug therapy</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Education</name>
        </item>
        <item>
          <name>Electronic data interchange</name>
        </item>
        <item>
          <name>Emergency medicine</name>
        </item>
        <item>
          <name>Employee benefit plans</name>
        </item>
        <item>
          <name>Employee health benefits</name>
        </item>
        <item>
          <name>Families</name>
        </item>
        <item>
          <name>Federal Trade Commission</name>
        </item>
        <item>
          <name>Federal advisory bodies</name>
        </item>
        <item>
          <name>Federal aid to health facilities</name>
        </item>
        <item>
          <name>Fees</name>
        </item>
        <item>
          <name>Finance and Financial Sector</name>
        </item>
        <item>
          <name>Fines (Penalties)</name>
        </item>
        <item>
          <name>Fraud</name>
        </item>
        <item>
          <name>Generic drugs</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government trust funds</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Grants-in-aid</name>
        </item>
        <item>
          <name>Health care fraud</name>
        </item>
        <item>
          <name>Health education</name>
        </item>
        <item>
          <name>Health information systems</name>
        </item>
        <item>
          <name>Health insurance</name>
        </item>
        <item>
          <name>Health insurance continuation</name>
        </item>
        <item>
          <name>Health maintenance organizations</name>
        </item>
        <item>
          <name>Health services administration</name>
        </item>
        <item>
          <name>Home care services</name>
        </item>
        <item>
          <name>Hospitals</name>
        </item>
        <item>
          <name>Housing and Community Development</name>
        </item>
        <item>
          <name>Immunosuppressive drugs</name>
        </item>
        <item>
          <name>Imports</name>
        </item>
        <item>
          <name>Independent regulatory commissions</name>
        </item>
        <item>
          <name>Information networks</name>
        </item>
        <item>
          <name>Injunctions</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Judicial opinions</name>
        </item>
        <item>
          <name>Judicial review</name>
        </item>
        <item>
          <name>Kidney diseases</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Labor and Employment</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Mail-order business</name>
        </item>
        <item>
          <name>Managed care</name>
        </item>
        <item>
          <name>Marketing</name>
        </item>
        <item>
          <name>Medicaid</name>
        </item>
        <item>
          <name>Medical economics</name>
        </item>
        <item>
          <name>Medical fees</name>
        </item>
        <item>
          <name>Medical records</name>
        </item>
        <item>
          <name>Medical statistics</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Medication abuse</name>
        </item>
        <item>
          <name>Medigap</name>
        </item>
        <item>
          <name>Metropolitan areas</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Patents</name>
        </item>
        <item>
          <name>Patients' rights</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Pharmacies</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
        <item>
          <name>Quality control</name>
        </item>
        <item>
          <name>Rebates</name>
        </item>
        <item>
          <name>Restrictive trade practices</name>
        </item>
        <item>
          <name>Retiree health benefits</name>
        </item>
        <item>
          <name>Right of petition</name>
        </item>
        <item>
          <name>Right of privacy</name>
        </item>
        <item>
          <name>Rural health</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
        <item>
          <name>Standards</name>
        </item>
        <item>
          <name>Surveys</name>
        </item>
        <item>
          <name>Technological innovations</name>
        </item>
        <item>
          <name>Territories (U.S.)</name>
        </item>
        <item>
          <name>Transplantation of organs, tissues, etc.</name>
        </item>
        <item>
          <name>Urban affairs</name>
        </item>
        <item>
          <name>Veterans' benefits</name>
        </item>
        <item>
          <name>Veterans' medical care</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2003-01-07</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2006-11-28T17:35:40Z</updateDate>
        <text><![CDATA[Prescription Drug Benefit and Cost Containment Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to establish: (1) a Medicare Outpatient Prescription Drug Benefit Program under new part D; (2) a Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund; and (3) a Medicare Prescription Drug Advisory Committee.<p>Provides for: (1) part D benefits under Medicare+Choice plans under Medicare part C (Medicare+Choice); and (2) Medicare cost-sharing and other assistance for low-income individuals.<p>Revises requirements for Medicare supplemental insurance policy (Medigap) benefit packages to conform to changes made by this Act.<p>Provides for coverage of immunosuppressive drugs for all Medicare beneficiaries under Medicare part B (Supplementary Medical Insurance).<p>Directs the Secretary of Health and Human Services to study and report to Congress on the feasibility and advisability of establishing a uniform format for pharmacy benefit cards provided to beneficiaries.<p>Expands the membership and duties of the Medicare Payment Advisory Commission (MEDPAC).<p>Amends the Federal Food, Drug, and Cosmetic Act to revise provisions concerning the timing of generic drug availability.<p>Requires applicants (pharmaceutical companies) to register their patents with the Food and Drug Administration (FDA) within 30 days of approval (or issuance for subsequently issued patents). Makes failure to timely register a bar to civil actions for patent infringement.<p>Requires applications for new drugs (NDA) or abbreviated new drug applications (ANDA) which rely upon investigations not conducted by or for the applicant and which concern a patent that claims both the drug and a method of use or more than one method of use to include a certification on a claim-by-claim basis that the patent is invalid or will not be infringed (known as a Paragraph IV filing/certification) by the new drug's (generic) manufacture and a statement regarding the method(s) of use claim.<p>Prohibits (for subsequently issued patents) an extension of the 30-month stay of FDA approval for any new drug where an ANDA or NDA contains a Paragraph IV filing/certification and the patent holder indicates an intention to bring a patent infringement suit against the new (generic) drug's manufacturer. Makes failure to timely file a civil action for infringement a bar to later action.<p>Requires the first generic applicant with a Paragraph IV filing to forfeit the 180 day marketing exclusivity period to a subsequent generic applicant if the first generic applicant engages in certain behaviors (forfeiture events) which delay or prevent the marketing of the generic drug.<p>Adds provisions on importation of prescription drugs and pediatric labeling of drugs and biological products.]]></text>
      </summary>
    </summaries>
    <title>Prescription Drug Benefit and Cost Containment Act of 2003</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Prescription Drug Benefit and Cost Containment Act of 2003</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend title XVIII of the Social Security Act to provide coverage of outpatient prescription drugs under the medicare program and to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Prescription Drug Benefit and Cost Containment Act of 2003</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2003-01-07T05:00:00Z</date>
        <formats/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2003-01-07</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
